BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
BioInvent International EPS Diluted (Quarterly) : -0.1995 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1995 |
| March 31, 2026 | -0.1982 |
| December 31, 2025 | -0.2032 |
| September 30, 2025 | -0.2063 |
| June 30, 2025 | 0.061 |
| March 31, 2025 | -0.1661 |
| December 31, 2024 | -0.1648 |
| September 30, 2024 | -0.1418 |
| June 30, 2024 | -0.1952 |
| March 31, 2024 | -0.1139 |
| December 31, 2023 | -0.1384 |
| September 30, 2023 | -0.0999 |
| June 30, 2023 | -0.1274 |
| March 31, 2023 | -0.1073 |
| December 31, 2022 | -0.1124 |
| September 30, 2022 | -0.0948 |
| June 30, 2022 | 0.2908 |
| March 31, 2022 | -0.124 |
| December 31, 2021 | -0.152 |
| September 30, 2021 | -0.1238 |
| June 30, 2021 | -0.1165 |
| March 31, 2021 | -0.2309 |
| December 31, 2020 | 0.0841 |
| September 30, 2020 | -0.1128 |
| June 30, 2020 | -0.171 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.165 |
| December 31, 2019 | -0.2084 |
| September 30, 2019 | -0.1895 |
| June 30, 2019 | -0.182 |
| March 31, 2019 | -0.2012 |
| December 31, 2018 | -0.2523 |
| September 30, 2018 | -0.1643 |
| June 30, 2018 | -0.3386 |
| March 31, 2018 | -0.2415 |
| December 31, 2017 | -0.3239 |
| September 30, 2017 | -0.2107 |
| June 30, 2017 | -0.2227 |
| March 31, 2017 | -0.1922 |
| December 31, 2016 | -0.0541 |
| September 30, 2016 | -0.2874 |
| June 30, 2016 | -0.2981 |
| March 31, 2016 | 0.0058 |
| December 31, 2015 | -0.3469 |
| September 30, 2015 | -0.3742 |
| June 30, 2015 | -0.5122 |
| March 31, 2015 | -0.4666 |
| December 31, 2014 | -0.6893 |
| September 30, 2014 | -0.2654 |
| June 30, 2014 | 0.1241 |
| March 31, 2014 | -0.6657 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 0.1309 |
| Hansa Biopharma AB | -0.279 |
| BioArctic AB | -0.0134 |
| Swedish Orphan Biovitrum AB | 0.1673 |
| Diamyd Medical AB | -0.0909 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.12M |
| Revenue (Quarterly) | 1.362M |
| Total Expenses (Quarterly) | 14.49M |
| Enterprise Value | 183.41M |
| Profit Margin (Quarterly) | -964.0% |
| Earnings Yield | -24.55% |
| Normalized Earnings Yield | -24.55 |